Molecular mechanisms that confer antibacterial drug resistance (Q33915635)

30 July 2017

1 reference

title

Molecular mechanisms that confer antibacterial drug resistance (English)

1 reference

30 July 2017

Walsh C

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

30 July 2017

number of pages

7

1 reference

inferred from page(s)

published in

Nature

1 reference

30 July 2017

volume

406

1 reference

30 July 2017

issue

6797

1 reference

30 July 2017

page(s)

775-781

1 reference

The crisis in antibiotic resistance

30 July 2017

cites work

1 reference

7 January 2021

The challenge of antibiotic resistance

1 reference

7 January 2021

Multidrug resistance--a sign of the times

1 reference

7 January 2021

Penicillin-binding proteins of gram-negative bacteria

1 reference

7 January 2021

The glycopeptide story--how to kill the deadly 'superbugs'.

1 reference

7 January 2021

Mechanism of action of spiramycin and other macrolides

1 reference

7 January 2021

Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic

1 reference

7 January 2021

Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center

1 reference

7 January 2021

DNA gyrase as a drug target

1 reference

7 January 2021

Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus

1 reference

7 January 2021

Bacteria on the rampage

1 reference

7 January 2021

Vancomycin-resistant enterococci

1 reference

7 January 2021

Genetics and mechanisms of glycopeptide resistance in enterococci

1 reference

7 January 2021

Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story

1 reference

7 January 2021

Inactivation of antibiotics and the dissemination of resistance genes

1 reference

7 January 2021

Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control

1 reference

7 January 2021

New mechanisms of bacterial resistance to antimicrobial agents

1 reference

7 January 2021

Active efflux mechanisms for antimicrobial resistance

1 reference

7 January 2021

Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family

1 reference

7 January 2021

Evolution of plasmid-coded resistance to broad-spectrum cephalosporins

1 reference

7 January 2021

Structure of an enzyme required for aminoglycoside antibiotic resistance reveals homology to eukaryotic protein kinases

1 reference

7 January 2021

Crystal structure of ErmC', an rRNA methyltransferase which mediates antibiotic resistance in bacteria

1 reference

7 January 2021

Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA.

1 reference

7 January 2021

Evolution of an inducible penicillin-target protein in methicillin-resistant Staphylococcus aureus by gene fusion

1 reference

7 January 2021

Resistance to antibiotics mediated by target alterations

1 reference

7 January 2021

Molecular requirements for the inhibition of the tetracycline antiport protein and the effect of potent inhibitors on the growth of tetracycline-resistant bacteria.

1 reference

7 January 2021

New directions in antibacterial research

1 reference

7 January 2021

In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide

1 reference

7 January 2021

An analysis of the origins of a cooperative binding energy of dimerization

1 reference

7 January 2021

Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala.

1 reference

7 January 2021

Deconstructing vancomycin.

1 reference

7 January 2021

In vitro activities of a streptogramin (RP59500), three macrolides, and an azalide against four respiratory tract pathogens

1 reference

7 January 2021

Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort

1 reference

7 January 2021

Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.

1 reference

7 January 2021

3D structure of ramoplanin: a potent inhibitor of bacterial cell wall synthesis

1 reference

7 January 2021

The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics

1 reference

7 January 2021

Crystal structure of the Escherichia coli peptide deformylase

1 reference

7 January 2021

Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor

1 reference

7 January 2021

Bacterial protein secretion--a target for new antibiotics?

1 reference

7 January 2021

Two-component signal transduction as a target for microbial anti-infective therapy

1 reference

7 January 2021

Quorum sensing by peptide pheromones and two‐component signal‐transduction systems in Gram‐positive bacteria

1 reference

7 January 2021

The global activator GacA of Pseudomonas aeruginosa PAO positively controls the production of the autoinducer N-butyryl-homoserine lactone and the formation of the virulence factors pyocyanin, cyanide, and lipase

1 reference

7 January 2021

Discovery of novel disaccharide antibacterial agents using a combinatorial library approach

1 reference

7 January 2021

Combinatorial approaches to polyketide biosynthesis

1 reference

7 January 2021

Manipulation of Modular Polyketide Synthases.

1 reference

7 January 2021

Harnessing the Biosynthetic Potential of Modular Polyketide Synthases

1 reference

7 January 2021

Harnessing the biosynthetic code: combinations, permutations, and mutations

1 reference

7 January 2021

Multiple genetic modifications of the erythromycin polyketide synthase to produce a library of novel "unnatural" natural products.

1 reference

7 January 2021

New resistance in Staphylococcus aureus.

1 reference

7 January 2021

Medical consequences of antibiotic use in agriculture.

1 reference

7 January 2021

Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia

1 reference

7 January 2021

Identifiers

DOI

10.1038/35021219

1 reference

Dimensions Publication ID

30 July 2017

1027242102

0 references

1 reference